Trial site
Medical Research Group of Central Florida
- 4running trials
- 7closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Tourette syndrome2 trials
- Depression1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.3 trials
- Eli Lilly and Company2 trials
- Emalex Biosciences Inc.2 trials
- Boehringer Ingelheim1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
Closed trials
Completed
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Completed
Completed
Completed
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Completed
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Completed
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Site data: ClinicalTrials.govUpdated 18 Nov 2026